These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12193583)

  • 1. Ovarian hyperstimulation by LH leads to mammary gland hyperplasia and cancer predisposition in transgenic mice.
    Milliken EL; Ameduri RK; Landis MD; Behrooz A; Abdul-Karim FW; Keri RA
    Endocrinology; 2002 Sep; 143(9):3671-80. PubMed ID: 12193583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The permissive role of prolactin as a regulator of luteinizing hormone action in the female mouse ovary and extragonadal tumorigenesis.
    Bachelot A; Carré N; Mialon O; Matelot M; Servel N; Monget P; Ahtiainen P; Huhtaniemi I; Binart N
    Am J Physiol Endocrinol Metab; 2013 Oct; 305(7):E845-52. PubMed ID: 23921141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous pituitary abnormalities and mammary hyperplasia in FVB/NCr mice: implications for mouse modeling.
    Wakefield LM; Thordarson G; Nieto AI; Shyamala G; Galvez JJ; Anver MR; Cardiff RD
    Comp Med; 2003 Aug; 53(4):424-32. PubMed ID: 14524419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human chorionic gonadotropin (hCG) up-regulates wnt5b and wnt7b in the mammary gland, and hCGbeta transgenic female mice present with mammary Gland tumors exhibiting characteristics of the Wnt/beta-catenin pathway activation.
    Kuorelahti A; Rulli S; Huhtaniemi I; Poutanen M
    Endocrinology; 2007 Aug; 148(8):3694-703. PubMed ID: 17510243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
    Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
    Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local over-expression of prolactin in differentiating mouse mammary gland induces functional defects and benign lesions, but no carcinoma.
    Manhès C; Kayser C; Bertheau P; Kelder B; Kopchick JJ; Kelly PA; Touraine P; Goffin V
    J Endocrinol; 2006 Aug; 190(2):271-85. PubMed ID: 16899561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian hyperstimulation induces centrosome amplification and aneuploid mammary tumors independently of alterations in p53 in a transgenic mouse model of breast cancer.
    Milliken EL; Lozada KL; Johnson E; Landis MD; Seachrist DD; Whitten I; Sutton AL; Abdul-Karim FW; Keri RA
    Oncogene; 2008 Mar; 27(12):1759-66. PubMed ID: 17891171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prostaglandin E2 receptor EP2 is required for cyclooxygenase 2-mediated mammary hyperplasia.
    Chang SH; Ai Y; Breyer RM; Lane TF; Hla T
    Cancer Res; 2005 Jun; 65(11):4496-9. PubMed ID: 15930264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hyperplastic phenotype in PR-A and PR-B transgenic mice: lessons on the role of estrogen and progesterone receptors in the mouse mammary gland and breast cancer.
    Sampayo R; Recouvreux S; Simian M
    Vitam Horm; 2013; 93():185-201. PubMed ID: 23810007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pleiotropic effects of excessive luteinizing hormone secretion in transgenic mice.
    Sutton AL; Keri RA
    Semin Reprod Med; 2007 Sep; 25(5):360-7. PubMed ID: 17710732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of endocrine, autocrine, and paracrine interactions in the development of mammary hyperplasia in Wnt-1 transgenic mice.
    Lin TP; Guzman RC; Osborn RC; Thordarson G; Nandi S
    Cancer Res; 1992 Aug; 52(16):4413-9. PubMed ID: 1386556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperplasia and impaired involution in the mammary gland of transgenic mice expressing human FGF4.
    Morini M; Astigiano S; Mora M; Ricotta C; Ferrari N; Mantero S; Levi G; Rossini M; Barbieri O
    Oncogene; 2000 Dec; 19(52):6007-14. PubMed ID: 11146552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of the colony-stimulating factor (CSF-1) and/or its receptor c-fms in mammary glands of transgenic mice results in hyperplasia and tumor formation.
    Kirma N; Luthra R; Jones J; Liu YG; Nair HB; Mandava U; Tekmal RR
    Cancer Res; 2004 Jun; 64(12):4162-70. PubMed ID: 15205327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consequences of elevated luteinizing hormone on diverse physiological systems: use of the LHbetaCTP transgenic mouse as a model of ovarian hyperstimulation-induced pathophysiology.
    Mann RJ; Keri RA; Nilson JH
    Recent Prog Horm Res; 2003; 58():343-75. PubMed ID: 12795427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAK1 hyperactivation is sufficient for mammary gland tumor formation.
    Wang RA; Zhang H; Balasenthil S; Medina D; Kumar R
    Oncogene; 2006 May; 25(20):2931-6. PubMed ID: 16331248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.
    Bocchinfuso WP; Hively WP; Couse JF; Varmus HE; Korach KS
    Cancer Res; 1999 Apr; 59(8):1869-76. PubMed ID: 10213494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice.
    Krane IM; Leder P
    Oncogene; 1996 Apr; 12(8):1781-8. PubMed ID: 8622899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-alpha promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells.
    Smith GH; Sharp R; Kordon EC; Jhappan C; Merlino G
    Am J Pathol; 1995 Oct; 147(4):1081-96. PubMed ID: 7573353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt1 is epistatic to Id2 in inducing mammary hyperplasia, ductal side-branching, and tumors in the mouse.
    Marino S; Romelfanger C; Yokota Y; Nusse R
    BMC Cancer; 2004 Dec; 4():91. PubMed ID: 15601467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mice heterozygous for a Brca1 or Brca2 mutation display distinct mammary gland and ovarian phenotypes in response to diethylstilbestrol.
    Bennett LM; McAllister KA; Malphurs J; Ward T; Collins NK; Seely JC; Gowen LC; Koller BH; Davis BJ; Wiseman RW
    Cancer Res; 2000 Jul; 60(13):3461-9. PubMed ID: 10910057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.